HCRN-LUN88-4

Phase II Trial of Daily Oral Etoposide in Refractory Small Cell Lung Cancer

Status

Study Completed

Cancer Type(s)

Study Contact

Trial Locations

All sites in which the trial HCRN-LUN88-4 being conducted in.
No data was found